Global Insomnia Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global Insomnia Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
Chapter 1 Insomnia Market Overview
1.1 Insomnia Definition
1.2 Global Insomnia Market Size Status and Outlook (2019-2032)
1.3 Global Insomnia Market Size Comparison by Region (2019-2032)
1.4 Global Insomnia Market Size Comparison by Type (2019-2032)
1.5 Global Insomnia Market Size Comparison by Application (2019-2032)
1.6 Global Insomnia Market Size Comparison by Sales Channel (2019-2032)
1.7 Insomnia Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global Insomnia Market Snapshot
2.2 Global Insomnia Market Volume & Revenue (2019-2025)
2.3 Global Insomnia Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global Insomnia Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global Insomnia Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global Insomnia Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 Insomnia Market Segment Analysis by Player
3.1 Global Insomnia Sales and Market Share by Player (2023-2025)
3.2 Global Insomnia Revenue and Market Share by Player (2023-2025)
3.3 Global Insomnia Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 Insomnia Market Segment Analysis by Type
4.1 Global Insomnia Market by Type
4.1.1 Benzodiazepines
4.1.2 Nonbenzodiazepines
4.1.3 Antidepressants
4.1.4 Orexin Antagonists
4.1.5 Melatonin Antagonists
4.2 Global Insomnia Sales and Market Share by Type (2019-2025)
4.3 Global Insomnia Revenue and Market Share by Type (2019-2025)
4.4 Global Insomnia Average Price by Type (2019-2025)
4.5 Leading Players of Insomnia by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 Insomnia Market Segment Analysis by Application
5.1 Global Insomnia Market by Application
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.2 Global Insomnia Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of Insomnia by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 Insomnia Market Segment Analysis by Sales Channel
6.1 Global Insomnia Market by Sales Channel
6.1.1 Global Insomnia Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global Insomnia Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global Insomnia Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of Insomnia by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 Insomnia Market Segment Analysis by Region
7.1 Global Insomnia Market Size and CAGR by Region (2019-2032)
7.2 Global Insomnia Sales and Market Share by Region (2019-2025)
7.3 Global Insomnia Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America Insomnia Market Share by Type
7.4.3 North America Insomnia Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe Insomnia Market Share by Type
7.5.3 Europe Insomnia Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific Insomnia Market Share by Type
7.6.3 Asia-Pacific Insomnia Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America Insomnia Market Share by Type
7.7.3 South America Insomnia Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa Insomnia Market Share by Type
7.8.3 Middle East & Africa Insomnia Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading Insomnia Players
8.1 Meda Consumer Healthcare
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 Takeda Pharmaceuticals
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 Pfizer
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 Sanofi
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Vanda Pharmaceuticals
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Pernix Therapeutics
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Purdue Pharmaceuticals
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 Mylan
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 Teva Pharmaceutical
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 Sumitomo Dainippon Pharma
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
8.11 Paratek Pharmaceuticals
8.11.1 Company Snapshot
8.11.2 Product/Service Offered
8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.11.4 Recent Developments
8.12 Ebb Therapeutics
8.12.1 Company Snapshot
8.12.2 Product/Service Offered
8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.12.4 Recent Developments
8.13 Astellas
8.13.1 Company Snapshot
8.13.2 Product/Service Offered
8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.13.4 Recent Developments
8.14 Dainippon Sumitomo
8.14.1 Company Snapshot
8.14.2 Product/Service Offered
8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.14.4 Recent Developments
8.15 Flynn Pharma
8.15.1 Company Snapshot
8.15.2 Product/Service Offered
8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.15.4 Recent Developments
8.16 Johnson & Johnson
8.16.1 Company Snapshot
8.16.2 Product/Service Offered
8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.16.4 Recent Developments
8.17 Somnus Therapeutics
8.17.1 Company Snapshot
8.17.2 Product/Service Offered
8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.17.4 Recent Developments
8.18 Neurim
8.18.1 Company Snapshot
8.18.2 Product/Service Offered
8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.18.4 Recent Developments
8.19 Minerva Neurosciences
8.19.1 Company Snapshot
8.19.2 Product/Service Offered
8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.19.4 Recent Developments
8.20 SkyePharma
8.20.1 Company Snapshot
8.20.2 Product/Service Offered
8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.20.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of Insomnia
9.1 Industrial Chain of Insomnia
9.2 Upstream of Insomnia
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of Insomnia
9.3.1 Leading Distributors/Dealers of Insomnia
9.3.2 Leading Consumers of Insomnia
Chapter 10. Global Insomnia Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global Insomnia Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. Insomnia Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of Insomnia (2026-2032)
11.1 Global Insomnia Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global Insomnia Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global Insomnia Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global Insomnia Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global Insomnia Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America Insomnia Import-Export (2019-2025)
12.2 Europe Insomnia Import-Export (2019-2025)
12.3 Asia Pacific Insomnia Import-Export (2019-2025)
12.4 South America Insomnia Import-Export (2019-2025)
12.5 Middle East & Africa Insomnia Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America Insomnia Demand-Supply (2019-2025)
13.2 Europe Insomnia Demand-Supply (2019-2025)
13.3 Asia Pacific Insomnia Demand-Supply (2019-2025)
13.4 South America Insomnia Demand-Supply (2019-2025)
13.5 Middle East & Africa Insomnia Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.